Daily Round Up 4/21/16: Summit Midstream, RVUE, Wells Fargo Multi Sector Income Fund, Virtus Total Return Fund

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 4/21/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at:

  • Summit Midstream (NYSE:SMLP);
  • Wells Fargo Multi Sector Income Fund (NYSEMKT:ERC), and;
  • Virtus Total Return Fund (NYSE:DCA).

Insider trades were rated Nearly Significant at:

  • Cellectar Biosciences (NASDAQ:CLRB);
  • Lmp Real Estate Income Fund (NYSE:RIT);
  • AC Convertible & Inc (NYSE:AGC);
  • Sage Therapeutics (NASDAQ:SAGE), and;
  • Summit Materials (NYSE:SUM).

Insider trades were considered Insignificant at:

  • Performance Sports (NYSE:PSG);
  • Stryker (NYSE:SYK);
  • Liberty Interactive (NASDAQ:QVCA);
  • Pacwest Bancorp (NASDAQ:PACW), and;
  • Universal Display (NASDAQ:OLED).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Schwab Charles (NYSE:SCHW);
  • Five Prime Therap (NASDAQ:FPRX), and;
  • Fiserv (NASDAQ:FISV).

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Saba Capital Mgt BO Wells Fargo Multi Sector Income Fund ERC B $2,177,099
2 Energy Capital II DIR,BO Summit Midstream SMLP AB $882,925
3 Neis John DIR Cellectar Biosciences CLRB JB* $497,653
4 Berger Franklin M DIR Five Prime Therap FPRX B $286,607
5 Bulldog Investors BO Lmp Real Estate Income Fund RIT B $262,127
6 Saba Capital Mgt BO AC Convertible & Inc AGC B $256,723
7 Bulldog Investors BO Virtus Total Return Fund DCA B $158,985
8 Jacobi C Michael DIR Performance Sports PSG B $109,780
9 Caruso James V CEO,DIR Cellectar Biosciences CLRB JB* $99,530
10 Roche Robert W DIR,BO RVUE RVUE JB* $90,000
Click to enlarge

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Blackstone II BO Summit Materials SUM JS* $185,447,552
2 Schwab Charles CB,DIR,BO Schwab Charles SCHW S $16,253,468
3 Gardner Ted A DIR Summit Materials SUM JS* $11,456,080
4 Vadon Mark C DIR Liberty Interactive QVCA AS $3,575,403
5 Erickson Matthew PR,COO ZAYO ZAYO AS $2,115,488
6 Rosenblatt Sidney D VP,CFO,DIR Universal Display OLED AS $1,508,745
7 Stryker Ronda E DIR Stryker SYK AS $1,313,111
8 Yabuki Jeffery W CEO,DIR Fiserv FISV AS $1,198,800
9 Brennan Suzanne R VP Pacwest Bancorp PACW S $800,118
10 Kanes Stephen O Sage Therapeutics SAGE AS $798,000
Click to enlarge | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.